The STAR™ Tumor Ablation Registry

NCT02419703 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2017-04-12

No results posted yet for this study

Summary

Registry collecting data on use of The STAR™ Tumor Ablation System.

Conditions

  • Metastatic Lesions in Vertebral Bodies

Interventions

DEVICE

STAR™ Tumor Ablation System

Targeted Radiofrequency ablation of painful metastatic tumor in the vertebral body.

Sponsors & Collaborators

  • DFINE Inc.

    collaborator INDUSTRY
  • Merit Medical Systems, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-03-20
Completion
2017-03-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02419703 on ClinicalTrials.gov